Inflammation and depression: Is there a causal connection with dementia?
暂无分享,去创建一个
[1] Roger M. Nitsch,et al. Serotonin 5-HT2a and 5-HT2c Receptors Stimulate Amyloid Precursor Protein Ectodomain Secretion (*) , 1996, The Journal of Biological Chemistry.
[2] B. Roth,et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗ ∗ See accompanying Editorial, in this issue. , 1999, Biological Psychiatry.
[3] F. Jessen,et al. Early-Onset and Late-Onset Depression Are Independent of the Genetic Polymorphism of Apolipoprotein E , 1999, Dementia and Geriatric Cognitive Disorders.
[4] D. Munn,et al. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? , 1999, Immunology today.
[5] J. Mendlewicz,et al. Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex , 1997, British Journal of Psychiatry.
[6] D. Steffens,et al. ApoE genotype and hippocampal volume change in geriatric depression , 2002, Biological Psychiatry.
[7] H. Wagner,et al. Hippocampal volume and incident dementia in geriatric depression. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[8] S. Southwick,et al. Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder. , 2000, The American journal of psychiatry.
[9] M. Raichle,et al. Subgenual prefrontal cortex abnormalities in mood disorders , 1997, Nature.
[10] R. S. Smith. The macrophage theory of depression. , 1991, Medical hypotheses.
[11] J. Jolles,et al. Distinction Between Preclinical Alzheimer's Disease and Depression , 2000, Journal of the American Geriatrics Society.
[12] R. Duman,et al. Repeated stress increases catalytic TrkB mRNA in rat hippocampus , 1999, Neuroscience Letters.
[13] B. Harvey. Affective Disorders and Nitric Oxide: A Role in Pathways to Relapse and Refractoriness? , 1996 .
[14] R Levy,et al. Neuropsychological deficits and CT scan changes in elderly depressives , 1990, Psychological Medicine.
[15] G. Buzsáki. Large-scale recording of neuronal ensembles , 2004, Nature Neuroscience.
[16] Seaver,et al. Nitric oxide as a secretory product of mammalian cells , 2004 .
[17] James T Becker,et al. Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. , 2002, The American journal of psychiatry.
[18] C. Nathan,et al. Nitric oxide as a secretory product of mammalian cells , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] C. Nemeroff,et al. Hypercortisolemia and hippocampal changes in depression , 1993, Psychiatry Research.
[20] E. Traggiai,et al. Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages , 2001, Journal of Neuroimmunology.
[21] R. Duman,et al. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[22] Glenda M MacQueen,et al. Course of illness, hippocampal function, and hippocampal volume in major depression , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[23] K. Welsh-Bohmer,et al. A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease. , 1997, Biological psychiatry.
[24] O. Hayaishi,et al. Biochemical and medical aspects of tryptophan metabolism : proceedings of the third international meeting of the International Study Group for Tryptophan Research held in Kyoto, Japan, August 4-7, 1980 , 1980 .
[25] D. Balota,et al. Relating anatomy to function in Alzheimer's disease , 1998, Neurology.
[26] J. Altman. Autoradiographic and histological studies of postnatal neurogenesis. IV. Cell proliferation and migration in the anterior forebrain, with special reference to persisting neurogenesis in the olfactory bulb , 1969, The Journal of comparative neurology.
[27] B. Brew,et al. Kynurenine pathway metabolism in human astrocytes. , 1999, Advances in experimental medicine and biology.
[28] H. Steinbusch,et al. Efavirenz Induces Depressive-Like Behaviour, Increased Stress Response and Changes in the Immune Response in Rats , 2005, Neuroimmunomodulation.
[29] E. Castrén,et al. Activation of the TrkB Neurotrophin Receptor Is Induced by Antidepressant Drugs and Is Required for Antidepressant-Induced Behavioral Effects , 2003, The Journal of Neuroscience.
[30] Michael A Rapp,et al. Neuropsychological differences between late-onset and recurrent geriatric major depression. , 2005, The American journal of psychiatry.
[31] J. Price,et al. Glial reduction in the subgenual prefrontal cortex in mood disorders. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[32] Yvette I. Sheline,et al. Depression Duration But Not Age Predicts Hippocampal Volume Loss in Medically Healthy Women with Recurrent Major Depression , 1999, The Journal of Neuroscience.
[33] C. Lyketsos,et al. Depression in Alzheimer’s disease: overview and treatment , 2002, Biological Psychiatry.
[34] W. Drevets,et al. The cellular neurobiology of depression , 2001, Nature Medicine.
[35] K. Marder,et al. Factors associated with incident human immunodeficiency virus-dementia. , 2001, Archives of neurology.
[36] B. Reisberg,et al. Vascular cognitive impairment , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[37] B. McEwen,et al. Possible mechanisms for atrophy of the human hippocampus , 1997, Molecular Psychiatry.
[38] J. Orav,et al. Depression in multiple sclerosis. , 1987, General hospital psychiatry.
[39] Michael A Rapp,et al. Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. , 2006, Archives of general psychiatry.
[40] R. Green,et al. Depression as a risk factor for Alzheimer disease: the MIRAGE Study. , 2003, Archives of neurology.
[41] C. Cotman,et al. Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus , 2000, Neuroscience.
[42] C. Shatz,et al. Synaptic Activity and the Construction of Cortical Circuits , 1996, Science.
[43] B. Stanfield,et al. Evidence that granule cells generated in the dentate gyrus of adult rats extend axonal projections , 2004, Experimental Brain Research.
[44] R. Grant,et al. Murine Glial Cells Regenerate NAD, After Peroxide‐Induced Depletion, Using Either Nicotinic Acid, Nicotinamide, or Quinolinic Acid as Substrates , 1998, Journal of neurochemistry.
[45] P. Landfield,et al. Evolving aspects of the glucocorticoid hypothesis of brain aging: Hormonal modulation of neuronal calcium homeostasis , 1994, Neurobiology of Aging.
[46] L. Crnic,et al. Anxiety Behavior, Exploratory Behavior, and Activity in NZB × NZW F1 Hybrid Mice: Role of Genotype and Autoimmune Disease Progression , 1996, Brain, Behavior, and Immunity.
[47] J. John Mann,et al. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims , 1995, Brain Research.
[48] D. Blazer. Depression in late life: review and commentary. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.
[49] Y. Kim,et al. Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. , 2003, Medical hypotheses.
[50] C. Pariante,et al. Glial cell abnormalities in major psychiatric disorders: the evidence and implications , 2001, Brain Research Bulletin.
[51] T. F. O'Brien,et al. Multipotent Stem/Progenitor Cells with Similar Properties Arise from Two Neurogenic Regions of Adult Human Brain , 1999, Experimental Neurology.
[52] Bin Liu,et al. Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention , 2003, Journal of Pharmacology and Experimental Therapeutics.
[53] R. Pihl,et al. Tryptophan depletion causes a rapid lowering of mood in normal males , 2004, Psychopharmacology.
[54] S. Moncada,et al. International Union of Pharmacology Nomenclature in Nitric Oxide Research. , 1997, Pharmacological reviews.
[55] M. Miller,et al. High-dimensional mapping of the hippocampus in depression. , 2003, The American journal of psychiatry.
[56] E. Major,et al. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. , 1993, Brain : a journal of neurology.
[57] R. Sapolsky,et al. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. , 2000, Archives of general psychiatry.
[58] Eric J. Nestler,et al. Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus , 2000, The Journal of Neuroscience.
[59] H. Steinbusch,et al. Kynurenine pathway in major depression: evidence of impaired neuroprotection. , 2007, Journal of affective disorders.
[60] B. Leonard. Brain cytokines and the psychopathology of depression , 2001 .
[61] B. Leonard,et al. Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. , 1994, Journal of affective disorders.
[62] Mikko Sairanen,et al. Brain-Derived Neurotrophic Factor and Antidepressant Drugs Have Different But Coordinated Effects on Neuronal Turnover, Proliferation, and Survival in the Adult Dentate Gyrus , 2005, The Journal of Neuroscience.
[63] M. Pericak-Vance,et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[64] C. Song,et al. The comparison of changes in behavior, neurochemistry, endocrine, and immune functions after different routes, doses and durations of administrations of IL-1beta in rats. , 2006, Pharmacopsychiatry.
[65] J. Altman,et al. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats , 1965, The Journal of comparative neurology.
[66] R. Hen,et al. Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants , 2003, Science.
[67] P. Mcgeer,et al. Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.
[68] I. Wicks,et al. Molecular targets in immune‐mediated diseases: the case of tumour necrosis factor and rheumatoid arthritis , 2003, Immunology and cell biology.
[69] B. Brew,et al. Expression of indoleamine 2,3‐dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons , 2005, Glia.
[70] Norio Matsuki,et al. Microglia‐specific expression of microsomal prostaglandin E2 synthase‐1 contributes to lipopolysaccharide‐induced prostaglandin E2 production , 2005, Journal of neurochemistry.
[71] D. Choi,et al. Quinolinate neurotoxicity in cortical cell culture , 1987, Neuroscience.
[72] J. Klein. Functions and pathophysiological roles of phospholipase D in the brain , 2005, Journal of neurochemistry.
[73] T. Stone,et al. An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid , 1982, Brain Research.
[74] M. Poo,et al. The cell biology of neuronal navigation , 2001, Nature Cell Biology.
[75] A. Valentine,et al. Neurological and Psychiatric Adverse Effects of Immunological Therapy , 1995 .
[76] P. Modrego,et al. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. , 2004, Archives of neurology.
[77] R. Duman. Novel therapeutic approaches beyond the serotonin receptor , 1998, Biological Psychiatry.
[78] J. Csernansky,et al. Hippocampal atrophy in recurrent major depression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[79] E. Vittinghoff,et al. Depressive affect and survival among gay and bisexual men infected with HIV. , 1996, Archives of internal medicine.
[80] E. Major,et al. Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. , 1992, The Biochemical journal.
[81] M. Maes,et al. IDO and interferon-α-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity , 2005, Molecular Psychiatry.
[82] J T O'Brien,et al. Clinical and Magnetic Resonance Imaging Correlates of Hypothalamic–Pituitary–Adrenal Axis Function in Depression and Alzheimer's Disease , 1996, British Journal of Psychiatry.
[83] M Ashtari,et al. Hippocampal/amygdala volumes in geriatric depression , 1999, Psychological Medicine.
[84] G. Adler,et al. Post-dexamethasone cortisol level and memory performance in elderly depressed patients , 2001, Neuroscience Letters.
[85] B. Brew,et al. Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection , 2001, Journal of neurochemistry.
[86] K. Krishnan,et al. Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations. , 1992, Archives of general psychiatry.
[87] M. Shenton,et al. Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma , 2002, Nature Neuroscience.
[88] Stephen J. Smith,et al. Neural activity and the dynamics of central nervous system development , 2004, Nature Neuroscience.
[89] S. Cohen-Cory. The Developing Synapse: Construction and Modulation of Synaptic Structures and Circuits , 2002, Science.
[90] S. Cuzzocrea,et al. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. , 2001, Pharmacological reviews.
[91] R. Duman,et al. Activation of cAMP Signaling Facilitates the Morphological Maturation of Newborn Neurons in Adult Hippocampus , 2004, The Journal of Neuroscience.
[92] James R MacFall,et al. Hippocampal volume in geriatric depression , 2000, Biological Psychiatry.
[93] T. Stone,et al. Endogenous kynurenines as targets for drug discovery and development , 2002, Nature Reviews Drug Discovery.
[94] David C. Steffens,et al. A twin study of late-onset depression and apolipoprotein E ε4 as risk factors for alzheimer's disease , 1997, Biological Psychiatry.
[95] P. Marshall. Allergy and depression: a neurochemical threshold model of the relation between the illnesses. , 1993, Psychological bulletin.
[96] Z. Kronfol,et al. Lymphocyte mitogenesis, immunoglobulin and complement levels in depressed patients and normal controls , 1989, Acta psychiatrica Scandinavica.
[97] S. Wesselingh,et al. Elevated central nervous system prostaglandins in human immunodeficiency virus—associated dementia , 1994, Annals of neurology.
[98] P. Greengard,et al. Protein phosphorylation inhibits production of Alzheimer amyloid beta/A4 peptide. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[99] J. Altman,et al. Autoradiographic and histological studies of postnatal neurogenesis. I. A longitudinal investigation of the kinetics, migration and transformation of cells incoorporating tritiated thymidine in neonate rats, with special reference to postnatal neurogenesis in some brain regions , 1966, The Journal of comparative neurology.
[100] B. Mulsant,et al. The temporal relationship between depressive symptoms and dementia: a community-based prospective study. , 1999, Archives of general psychiatry.
[101] T. Smith,et al. Low natural killer cytotoxicity in major depression. , 1987, Life sciences.
[102] E. Bosmans,et al. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. , 1997, Cytokine.
[103] R. Post,et al. Effects of Stress on Neurotrophic Factor Expression in the Rat Brain , 1995, Annals of the New York Academy of Sciences.
[104] Anil Gholkar,et al. A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. , 2004, The American journal of psychiatry.
[105] J. Siuciak,et al. Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures , 1999, Neuroscience.
[106] E. Bosmans,et al. The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. , 1998, Journal of affective disorders.
[107] R. Schiffer,et al. Affective disorders in multiple sclerosis. Review and recommendations for clinical research. , 1990, Archives of neurology.
[108] D. H. Bell,et al. Neuronal proliferation in the 9-month-old rodent — Radioautographic study of granule cells in the hippocampus , 2004, Experimental Brain Research.
[109] D. Longo,et al. Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes. , 1994, Blood.
[110] B. Sahakian,et al. Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed , 1996, Psychological Medicine.
[111] G. Niederehe,et al. Depression and memory impairment: a meta-analysis of the association, its pattern, and specificity. , 1995, Psychological bulletin.
[112] B. Lebowitz,et al. Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[113] C. Coffey,et al. Quantitative cerebral anatomy of the aging human brain , 1992, Neurology.
[114] J. Calabrese,et al. Depression, immunocompetence, and prostaglandins of the E series , 1986, Psychiatry Research.
[115] E. Bosmans,et al. Indicators of immune activation in major depression , 1996, Psychiatry Research.
[116] L. Staib,et al. Hippocampal volume reduction in major depression. , 2000, The American journal of psychiatry.
[117] Eric Vermetten,et al. Childhood trauma associated with smaller hippocampal volume in women with major depression. , 2002, The American journal of psychiatry.
[118] E. Borden,et al. Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures. , 1987, Journal of immunology.
[119] B. Leonard,et al. Changes in the immune system in depression and dementia: causal or coincidental effects? , 2006, Dialogues in clinical neuroscience.
[120] H. Steinbusch,et al. Th1, Th2, and Th3 cytokine alterations in major depression. , 2005, Journal of affective disorders.
[121] A. Beekman,et al. Depression and risk of cognitive decline and Alzheimer's disease , 2000, British Journal of Psychiatry.
[122] S. Weiss,et al. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. , 1992, Science.
[123] David C. Steffens,et al. Structural neuroimaging and mood disorders: Recent findings, implications for classification, and future directions , 1998, Biological Psychiatry.
[124] M Ashtari,et al. Qualitative magnetic resonance imaging findings in geriatric depression. Possible link between later-onset depression and Alzheimer's disease? , 1997, Psychological Medicine.
[125] Bruce S. McEwen,et al. Course of Illness, Hippocampal Function, and Hippocampal Volume in Major Depression , 2005 .
[126] W. Katon,et al. Depression and chronic medical illness. , 1990, The Journal of clinical psychiatry.